-
In vivo interaction of bacterial lipopolysaccharide (LPS) with rabbit platelets: modulation by C3 and high density lipoproteins.
J Immunol. 1981 Apr;126(4):1575-80
PMID: 7204977
-
Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey.
J Clin Invest. 1981 Dec;68(6):1503-13
PMID: 7033286
-
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.
Biochem Biophys Res Commun. 1978 Feb 28;80(4):849-57
PMID: 637870
-
The effect of complement depletion on bacterial lipopolysaccharide (LPS)-induced hemodynamic and hematologic changes in the Rhesus monkey.
Am J Pathol. 1978 Jul;92(1):227-40
PMID: 99042
-
The effects of bacterial endotoxins on host mediation systems. A review.
Am J Pathol. 1978 Nov;93(2):526-618
PMID: 362943
-
The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.
J Clin Invest. 1978 Dec;62(6):1313-24
PMID: 372234
-
Silver staining of proteins in polyacrylamide gels.
Anal Biochem. 1981 Nov 15;118(1):197-203
PMID: 6175245
-
Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides.
J Clin Invest. 1982 Oct;70(4):877-88
PMID: 6749904
-
The fate of interleukin-2 after in vivo administration.
J Immunol. 1983 May;130(5):2203-8
PMID: 6601147
-
In vitro production of rabbit macrophage tumor cell cytotoxin.
Int J Cancer. 1983 Jul 15;32(1):105-12
PMID: 6862689
-
Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1.
J Immunol. 1983 Sep;131(3):1160-6
PMID: 6604091
-
Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s).
J Immunol. 1983 Oct;131(4):1913-6
PMID: 6311900
-
Pharmacokinetic study of partially pure gamma-interferon in cancer patients.
Cancer Res. 1984 Sep;44(9):4164-71
PMID: 6430557
-
VARCOV: a computer program for the distribution-free analysis of growth and response curves.
Comput Programs Biomed. 1984;19(1):69-74
PMID: 6549282
-
Human tumor necrosis factor. Production, purification, and characterization.
J Biol Chem. 1985 Feb 25;260(4):2345-54
PMID: 3871770
-
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
Science. 1985 Aug 30;229(4716):869-71
PMID: 3895437
-
Purification and partial amino acid sequence of rabbit tumor necrosis factor.
Int J Cancer. 1985 Sep 15;36(3):395-400
PMID: 4030139
-
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.
Nature. 1985 Aug 8-14;316(6028):552-4
PMID: 2993897
-
Human interleukin 1 is a cytocidal factor for several tumor cell lines.
J Immunol. 1985 Dec;135(6):3962-8
PMID: 2415593
-
Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.
J Immunol. 1985 Dec;135(6):3972-7
PMID: 2999236
-
Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.
Proc Natl Acad Sci U S A. 1985 Dec;82(24):8667-71
PMID: 3866246
-
Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin.
Infect Immun. 1986 Mar;51(3):891-5
PMID: 3949385
-
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
J Exp Med. 1986 Mar 1;163(3):740-5
PMID: 3753996
-
Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers.
Am J Pathol. 1986 Apr;123(1):16-24
PMID: 2421578
-
Stimulation of neutrophils by tumor necrosis factor.
J Immunol. 1986 Jun 1;136(11):4220-5
PMID: 3009619
-
Cachectin and tumour necrosis factor as two sides of the same biological coin.
Nature. 1986 Apr 17-23;320(6063):584-8
PMID: 3010124
-
Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages.
Biochem Biophys Res Commun. 1986 Apr 14;136(1):94-101
PMID: 3486658
-
Molecular cloning and expression in Escherichia coli of the cDNA coding for rabbit tumor necrosis factor.
DNA. 1986 Apr;5(2):149-56
PMID: 3519137
-
An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism.
J Immunol. 1986 Jun 15;136(12):4548-53
PMID: 3486903
-
Pharmacokinetics of murine tumor necrosis factor.
J Immunopharmacol. 1986;8(1):89-97
PMID: 3711675
-
Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.
J Exp Med. 1986 Jun 1;163(6):1363-75
PMID: 3011946
-
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
J Exp Med. 1986 Jun 1;163(6):1433-50
PMID: 3486936
-
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7
PMID: 3487091
-
Tumor necrosis factor provokes superoxide anion generation from neutrophils.
Biochem Biophys Res Commun. 1986 Jun 30;137(3):1094-100
PMID: 3015137
-
Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.
J Exp Med. 1986 Sep 1;164(3):777-93
PMID: 2427635
-
Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.
Nature. 1986 Sep 4-10;323(6083):86-9
PMID: 3092113
-
Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor.
J Exp Med. 1986 Oct 1;164(4):1350-5
PMID: 3020152
-
Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential.
J Exp Med. 1986 Oct 1;164(4):1368-73
PMID: 3760781
-
Shock and tissue injury induced by recombinant human cachectin.
Science. 1986 Oct 24;234(4775):470-4
PMID: 3764421
-
Raised serum levels of tumour necrosis factor in parasitic infections.
Lancet. 1986 Dec 13;2(8520):1364-5
PMID: 2878227
-
Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients.
Scand J Immunol. 1986 Dec;24(6):739-43
PMID: 3798026
-
Tumour necrosis factor is a compact trimer.
FEBS Lett. 1987 Jan 26;211(2):179-84
PMID: 3803597
-
Secretory products of macrophages.
J Clin Invest. 1987 Feb;79(2):319-26
PMID: 3543052
-
Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
J Immunol. 1987 Feb 1;138(3):963-74
PMID: 3805720
-
Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.
Lancet. 1987 Feb 14;1(8529):355-7
PMID: 2880163
-
Cachectin: more than a tumor necrosis factor.
N Engl J Med. 1987 Feb 12;316(7):379-85
PMID: 3543677
-
Production of lymphotoxin and tumour necrosis factor by a T-cell hybridoma.
Immunology. 1987 Feb;60(2):213-7
PMID: 3102354
-
Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.
J Leukoc Biol. 1987 Mar;41(3):196-204
PMID: 3031189
-
Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.
Surg Gynecol Obstet. 1987 May;164(5):415-22
PMID: 3576418
-
The active form of tumor necrosis factor is a trimer.
J Biol Chem. 1987 May 25;262(15):6951-4
PMID: 3034874
-
Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
J Immunol. 1987 Jun 15;138(12):4298-302
PMID: 3495589
-
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Nature. 1987 Jun 11-17;327(6122):524-6
PMID: 3495737
-
The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors.
Proc Natl Acad Sci U S A. 1987 Jun;84(12):4273-7
PMID: 3108890
-
Acute in vivo effects of human recombinant tumor necrosis factor.
Lab Invest. 1987 Jun;56(6):583-90
PMID: 3599906
-
Estimation of 3-deoxy sugars by means of the malonaldehyde-thiobarbituric acid reaction.
Nature. 1960 Apr 9;186:155-6
PMID: 13813473
-
PLATELET SEQUESTRATION IN MAN. I. METHODS.
J Clin Invest. 1964 May;43:843-55
PMID: 14169513
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature. 1970 Aug 15;227(5259):680-5
PMID: 5432063
-
Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture.
Int Arch Allergy Appl Immunol. 1975;49(1-2):1-43
PMID: 1095497
-
Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement.
J Exp Med. 1975 Dec 1;142(6):1570-90
PMID: 1104750
-
Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo.
Infect Immun. 1976 Sep;14(3):626-30
PMID: 965087
-
Role of complement in lethal bacterial lipopolysaccharide-induced hypotensive and coagulative changes.
Infect Immun. 1978 Jan;19(1):204-11
PMID: 24001
-
Mechanisms of the hemodynamic effects of endotoxin.
Physiol Rev. 1960 Apr;40:245-79
PMID: 13850016
-
The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits.
J Immunol. 1979 Nov;123(5):2133-43
PMID: 489976
-
Free Endotoxin.
Nature. 1967 Jun 3;214(5092):1052
PMID: 4964234
-
A new method for the extraction of R lipopolysaccharides.
Eur J Biochem. 1969 Jun;9(2):245-9
PMID: 5804498
-
New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides.
J Clin Invest. 1979 Nov;64(5):1516-24
PMID: 227936
-
Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats.
Infect Immun. 1980 May;28(2):373-80
PMID: 7399668
-
Purification and physico-chemical characterization of rabbit tumor necrosis factor.
J Immunol. 1980 Oct;125(4):1671-7
PMID: 6997383